Pablo G. Legorreta's Net Worth
$1.83 Million
Who is Pablo G. Legorreta?
Pablo G. Legorreta has an estimated net worth of $1.83 Million. This is based on reported shares across multiple companies, which include Epizyme, Inc., Royalty Pharma plc, and PROKIDNEY CORP..
SEC CIK
Pablo G. Legorreta's CIK is 0001507678
Past Insider Trading and Trends
2021 was Pablo G. Legorreta's most active year for acquiring shares with 3 total transactions. Pablo G. Legorreta's most active month to acquire stocks was the month of April. 2022 was Pablo G. Legorreta's most active year for disposing of shares, totalling 3 transactions. Pablo G. Legorreta's most active month to dispose stocks was the month of July. 2021 saw Pablo G. Legorreta paying a total of $345,968.27 for 121,951 shares, this is the most they've acquired in one year. In 2023 Pablo G. Legorreta cashed out on 383,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Royalty Pharma plc (RPRX) Snapshot price: $28.72
CEO, Chairman the Board
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.32% | -90.81K |
—
|
—
| 355.99K |
Dec 30 - Nov 16
| |||
Form 4
| +27.66% | 130K |
$29.51 | $3,836,768.00 | 600K |
Jun 28
| |||
Form 4
| +23.68% | 90K |
$32.89 | $2,959,848.00 | 470K |
Jun 12 - Jun 13
| |||
Form 4
| +65.22% | 150K |
$32.25 | $4,837,440.00 | 380K |
May 24
| |||
Form 4
|
∞
| 230K |
$33.38 | $7,676,823.81 | 230K |
May 16 - May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +12.58% | 110.14K |
—
|
—
| 985.97K |
Jun 16 - Apr 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 2.33M |
—
|
—
| 2.33M |
May 7
| |||
Form 4
|
∞
| 261.81K |
$28.00 | $560,000.00 | 261.81K |
Jun 15 - Jun 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -31.93M |
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
| +247.27% | 22.67M |
$1.50 | $34,000,000.50 | 31.83M |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
| +37.50% | 2.5M |
$20.00 | $50,000,000.00 | 9.17M |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROKIDNEY CORP. (PROK) Snapshot price: $2.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 22.62M |
$2.42 | $54,735,339.78 | 22.62M |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||